Luciole Medical is a Swiss medical technology company developing brain oxygenation monitoring systems. The company has developed a unique proprietary technology making the measurement of the true oxygen content and blood flow of the brain tissue possible.
As well recognized the acute insufficient oxygen availability in the brain can have severe consequences. The chronically or temporary reduced/sub-acute oxygenation is often undetected and has serious consequences on the brain such as cognition impairment.
We want our technology and products to help patients and doctors.
Luciole Medical AG was founded in September 2017 in Zürich as a successor company of NemoDevices AG. Luciole Medical acquired all the rights and know-how pertaining to the system and development from NemoDevices. Key scientific, technical and regulatory team members are part of the restart project thus ensuring proper know-how transfer to Luciole Medical. Experienced medtech executives are supporting the project and the management and board will be further strengthened with medical device development and regulatory expertise.
The company is privately funded and is regularily looking for further investments in order to accelerate its development.
A company presentation can be found via the following link: